戻る
Zhaoke Ophthalmology Limited (06622.HK)価格
06622.HK 株価推移チャート
ZHAOKE OPHTH-B (06622.HK)
Zhaoke Ophthalmology Limited
HK$3.52
-0.84%
$-0.02
休場: Jan 16, 16:00:00 HKT
主要データ
前終値
$3.55
始値
$3.55
当日レンジ
$3.49 - $3.55
52週レンジ
$1.26 - $4.6
取引高
393.5K
平均取引高
1.0M
1株当たり利益(TTM)
-0.56
配当利回り
--
時価総額
$1.9B
ZHAOKE OPHTH-Bとは何ですか？
Zhaoke Ophthalmology Ltd. operates as holding company, which engages in the provision of ophthalmic pharmaceuticals. The company is headquartered in Guangzhou, Guangdong and currently employs 270 full-time employees. The company went IPO on 2021-04-29. The product pipelines primarily include NVK002 (Atropine) for myopia, CsA Ophthalmic Gel for DED and TAB014 (Bevacizumab) for wAMD. The products are primarily uses to treat eye diseases across both the front and the back of the eye, including dry eye disease (DED), myopia, presbyopia, wet age-related macular degeneration (wAMD) and diabetic macular edema (DME), glaucoma and corneal epithelial dysfunction (CED). The firm conducts its business in the domestic market and overseas markets.
